Sawstop Holding LLC v. Vidal ( 2022 )


Menu:
  • Case: 21-1537    Document: 50     Page: 1   Filed: 09/14/2022
    United States Court of Appeals
    for the Federal Circuit
    ______________________
    SAWSTOP HOLDING LLC,
    Plaintiff-Appellant
    v.
    KATHERINE K. VIDAL, UNDER SECRETARY OF
    COMMERCE FOR INTELLECTUAL PROPERTY
    AND DIRECTOR OF THE UNITED STATES
    PATENT AND TRADEMARK OFFICE,
    Defendant-Appellee
    ______________________
    2021-1537, 2021-2105
    ______________________
    Appeals from the United States District Court for the
    Eastern District of Virginia in Nos. 1:19-cv-01198-LMB-
    MSN, 1:20-cv-01212-LMB-MSN, Judge Leonie M.
    Brinkema.
    ______________________
    Decided: September 14, 2022
    ______________________
    JARED WESTON NEWTON, Quinn Emanuel Urquhart &
    Sullivan, LLP, Washington, DC, argued for plaintiff-appel-
    lant. Also represented by DAVID FANNING, SawStop, LLC,
    Tualatin, OR.
    HUGHAM CHAN, Office of the United States Attorney for
    the Eastern District of Virginia, United States Department
    of Justice, Alexandria, VA, argued for defendant-appellee.
    Case: 21-1537     Document: 50       Page: 2   Filed: 09/14/2022
    2                                 SAWSTOP HOLDING LLC   v. VIDAL
    Also represented by JESSICA D. ABER; KAKOLI CAPRIHAN,
    MICHAEL S. FORMAN, THOMAS W. KRAUSE, BRIAN RACILLA,
    FARHEENA YASMEEN RASHEED, Office of the Solicitor,
    United States Patent and Trademark Office, Alexandria,
    VA.
    ______________________
    Before NEWMAN, LINN, and CHEN, Circuit Judges.
    LINN, Circuit Judge.
    SawStop Holding LLC (“Sawstop”) appeals from the
    District Court’s grant of summary judgment in favor of the
    United States Patent and Trademark Office (“PTO”) in
    each of two suits filed by Sawstop to challenge the denial
    of patent term adjustments (“PTAs”) for Sawstop’s U.S. Pa-
    tent Nos. 9,522,476 (“’476 patent”) and 9,927,796 (“’796 pa-
    tent”). For the reasons discussed infra, we affirm.
    I
    To compensate for certain delays during prosecution of
    patents, Congress added provisions for patent term adjust-
    ment in the American Inventors Protection Act of 1999.
    The Act directs the PTO to grant patent term adjustments
    to offset three categories of prosecution delay set forth in
    
    35 U.S.C. § 154
    (b)(1)(A), (B), and (C). Subsection (A) delay
    accrues when the PTO fails in certain specified ways to
    timely respond to the applicant. Subsection (B) delay ac-
    crues when the PTO fails to issue a patent within a certain
    time from filing. Neither of those subsections is at issue in
    this case. At issue in this consolidated appeal is subsection
    (C) delay, which is codified in 
    35 U.S.C. § 154
    (b)(1)(C) and
    accrues for certain delays associated with appellate review.
    That provision reads, inter alia:
    Subject to the limitations under paragraph (2), if
    the issue of an original patent is delayed due to . . .
    (iii) appellate review by the Patent Trial
    and Appeal Board or by a Federal court in
    Case: 21-1537    Document: 50     Page: 3    Filed: 09/14/2022
    SAWSTOP HOLDING LLC   v. VIDAL                            3
    a case in which the patent was [1] issued
    under a decision in the review [2] reversing
    an adverse determination of patentability,
    the term of the patent shall be extended 1 day for
    each day of the pendency of the proceeding, order,
    or review, as the case may be.
    
    35 U.S.C. § 154
    (b)(1)(C) (emphasis added). The meanings
    of the two italicized phrases noted above are at the center
    of these appeals.
    The patents at issue in these cases are both directed to
    power saws with a safety feature that instantly stops the
    saw blade upon contact with flesh. Issuance of these pa-
    tents was delayed by appeals before allowance. For both
    patents, Sawstop requested PTA for (C) delay under the
    specific facts surrounding the appeals pursued in each
    case.
    With respect to the application that led to the issuance
    of the ’476 patent, claim 11 was finally rejected by the ex-
    aminer as being obvious over Figures 7–9 of Lokey, which
    show a table saw with a rubber block engaging to stop
    blade rotation, and Figures 1–5 of Lokey, which show a
    handheld saw with a pivoting cam brake, in combination
    with the disclosure of Fergle, which teaches an explosive
    actuator. Sawstop appealed that rejection to the Patent
    Trial and Appeal Board (“Board”).
    The Board held that “the examiner [did] not make suf-
    ficient findings regarding modifying the structure of
    Lokey’s embodiment of Figures 7–9 to incorporate cam
    brake members 24 of Lokey’s embodiment of Figures 1–5,”
    and thus concluded that “the Examiner [had] not made the
    initial factual findings required to demonstrate a prima fa-
    cie case of obviousness of claim 11.” J.A. 1826. Neverthe-
    less, the Board held that Lokey Figures 7–9 were sufficient
    in themselves to teach the pivotable component limitation
    in claim 11 and render claim 11 obvious in combination
    Case: 21-1537    Document: 50      Page: 4    Filed: 09/14/2022
    4                             SAWSTOP HOLDING LLC    v. VIDAL
    with Fergle.  It thus “AFFIRMED” the rejection of
    claim 11, J.A. 1829, on “a NEW GROUND OF
    REJECTION,” J.A. 1827.
    On remand, Sawstop reopened prosecution to address
    the new ground of rejection. It filed several amendments
    and a request for continued examination (“RCE”). The ex-
    aminer eventually allowed claim 11, which issued as
    claim 1 of the ’476 patent. The PTO made no adjustment
    to the term of the patent for the time spent on the appeal.
    Sawstop sought redetermination of that decision. The PTO
    denied Sawstop’s request. In doing so, the PTO cited the
    language of 
    35 U.S.C. § 154
    (b)(1)(C)(iii) and held that “the
    claim was not issued under a decision in the review revers-
    ing an adverse determination of patentability” because
    “the claim remain[ed] under rejection after the Board deci-
    sion” and “the patent only issue[d] after further prosecu-
    tion” and amendment. J.A. 2246–47.
    Thereafter, Sawstop filed a complaint in the District
    Court for the Eastern District of Virginia challenging the
    PTO’s interpretation of 
    35 U.S.C. § 154
    (b)(1)(C)(iii) and the
    denial of PTA under the Administrative Procedure Act
    (“APA”). Sawstop and the PTO filed cross motions for sum-
    mary judgment. The District Court denied Sawstop’s mo-
    tion and granted the government’s motion, holding that
    because claim 11 was subject to a new ground of rejection
    on appeal, the ’476 patent application was not “issued un-
    der a decision in the review reversing an adverse determi-
    nation of patentability,” and thus was not eligible for PTA
    under § 154(b)(1)(C)(iii). Sawstop Holding LLC v. Iancu,
    
    496 F. Supp. 3d 944
    , 950 (E.D. Va. 2020) (“’476 Decision”).
    With respect to the ’796 patent, prosecution culminated
    in the examiner finally rejecting independent claim 1 on
    two bases—anticipation and provisional non-statutory ob-
    viousness-type double patenting (“double patenting”)—and
    finally rejecting dependent claim 2 for anticipation. Saw-
    stop appealed all three rejections to the Board. The Board
    Case: 21-1537    Document: 50      Page: 5    Filed: 09/14/2022
    SAWSTOP HOLDING LLC   v. VIDAL                             5
    affirmed both rejections of claim 1, but reversed the antic-
    ipation rejection of claim 2, rendering it patentable.
    Sawstop then filed a complaint in the District Court for
    the District of Columbia challenging only the Board’s an-
    ticipation rejection of claim 1. The complaint did not ad-
    dress the provisional double patenting rejection.
    Ultimately, the District Court reversed the anticipation re-
    jection of claim 1. In doing so, it had no reason to and did
    not opine on the provisional double patenting rejection. On
    remand, the Board noted the outstanding provisional dou-
    ble patenting rejection, and gave Sawstop two options for
    allowance: Sawstop could file a terminal disclaimer or can-
    cel claim 1 and rewrite claim 2 as an independent claim.
    J.A. 877. Sawstop chose the latter.
    The Board thereafter issued a notice of allowance of
    claim 2 and other claims dependent therefrom.
    J.A. 887–88. Sawstop nevertheless filed an RCE and con-
    tinued prosecution through several additional amend-
    ments of the claims, drawings, and specifications.
    Eventually, the PTO issued a notice of allowance of the ’796
    patent.     The PTO granted PTA under 
    35 U.S.C. § 154
    (b)(1)(C)(iii) for the delay incurred in the successful
    reversal of the rejection of claim 2 at the Board. But the
    PTO denied any additional PTA for the delay caused by the
    appeal of claim 1 to the District Court.
    Like it did for the ’476 patent, Sawstop filed a com-
    plaint in the Eastern District of Virginia challenging that
    denial. The District Court entertained cross motions for
    summary judgment, ruling in favor of the PTO. It held that
    the ’796 patent was not entitled to PTA for Sawstop’s ap-
    peal to the District Court for the District of Columbia be-
    cause the appeal did not “revers[e] an adverse
    determination of patentability” as required by 
    35 U.S.C. § 154
    (b)(1)(C)(iii), as claim 1 remained subject to the out-
    standing provisional double patenting rejection and was
    thus unpatentable both before and after the appeal.
    Case: 21-1537     Document: 50      Page: 6   Filed: 09/14/2022
    6                              SAWSTOP HOLDING LLC    v. VIDAL
    Sawstop Holding LLC v. Hirshfeld, No. 1:20-cv-1212, 
    2021 WL 2021122
    , at *6–7 (E.D. Va. May 20, 2021) (“’796 Deci-
    sion”). The District Court also held that because claim 1
    was eventually cancelled and thus did not issue in the pa-
    tent, the ’796 patent did not “issue under” an adverse de-
    termination of patentability as that phrase is used in 
    35 U.S.C. § 154
    (b)(1)(C)(iii) and was not eligible for additional
    PTA for that independent reason. 
    Id. at *8
    .
    Sawstop appeals the summary judgments in both
    cases. We have jurisdiction over final decisions of the Dis-
    trict Court in these patent cases under 
    28 U.S.C. §§ 1291
    and 1295.
    II
    We review the grant of summary judgment according
    to the law of the regional circuit. Intra-Cellular Therapies,
    Inc. v. Iancu, 
    938 F.3d 1371
    , 1379 (Fed. Cir. 2019). The
    Fourth Circuit reviews the grant of summary judgment de
    novo. Norfolk S. Ry. Co. v. City of Alexandria, 
    608 F.3d 150
    , 156 (4th Cir. 2010).
    We review the PTO’s PTA award under the APA.
    Chudik v. Hirshfeld, 
    987 F.3d 1033
    , 1039 (Fed. Cir. 2021);
    
    35 U.S.C. § 154
    (b)(4)(A). The agency determination may
    be set aside only if it is “arbitrary, capricious, an abuse of
    discretion, or otherwise not in accordance with law.” 
    5 U.S.C. § 706
    (2)(A). Where administrative deference under
    Chevron is inapplicable, see Chevron, U.S.A., Inc. v. Nat’l
    Res. Def. Council, Inc., 
    467 U.S. 837
     (1984), or where the
    application of Chevron would make no difference to our in-
    terpretation of the statute, “we determine the ‘best inter-
    pretation’ of the statute for ourselves, while giving the
    agency’s position such weight as warranted under Skid-
    more.” Chudik, 987 F.3d at 1039 (quoting Rimini St. Inc.
    v. Oracle USA, Inc., 
    139 S.Ct. 873
    , 880 (2019) and citing
    Skidmore v. Swift & Co., 
    323 U.S. 134
    , 139–40 (1944)). In
    this case no deference is necessary under either Chevron or
    Case: 21-1537     Document: 50       Page: 7   Filed: 09/14/2022
    SAWSTOP HOLDING LLC   v. VIDAL                               7
    Skidmore as the plain language of § 154(b)(1)(C)(iii) com-
    pels affirmance.
    III
    In considering the meaning of the phrases at issue in
    
    35 U.S.C. § 154
    (b)(1)(C)(iii), we begin by reference to the
    plain language of the statute itself. United States v. Hohri,
    
    482 U.S. 64
    , 69 (1987). We recently held that the most nat-
    ural meaning of the words “appellate review by the Patent
    Trial and Appeal Board or by a Federal court in a case in
    which the patent was issued under a decision in the review
    reversing an adverse determination of patentability,” when
    applied to an examiner’s unpatentability ruling, requires
    that “the patent issue under a Board decision that reversed
    the examiner’s unpatentability ruling or under a court de-
    cision that reversed a Board unpatentability ruling in the
    matter.” Chudik, 987 F.3d at 1039–40. A “reversal” typi-
    cally means the undoing by an appellate tribunal of a rul-
    ing under review. See id. at 1040. “Type C adjustments
    are for delays that are . . . due to . . . successful appeals.”
    Supernus Pharms., Inc. v. Iancu, 
    913 F.3d 1351
    , 1353 (Fed.
    Cir. 2019).
    Here, the District Court held that, consistent with our
    past statutory construction of the (C) delay provision, the
    “unambiguous language imposes two requirements: that
    an adverse determination of patentability be reversed, and
    that the application reviewed in that appeal issue as a pa-
    tent as a result of that reversal.” ’796 Decision, 
    2021 WL 2021122
    , at *5; ’476 Decision, 496 F. Supp. 3d at 948. The
    District Court also concluded that the PTO did not demon-
    strate clear error in judgment in denying the requested
    PTA under 
    35 U.S.C. § 154
    (b)(1)(C)(iii) for the ’476 and ’796
    patents as neither patent met either requirement under
    the statute. We find no ambiguity in the language of the
    statute and agree with the conclusions reached by the Dis-
    trict Court for the reasons more fully set forth infra.
    Case: 21-1537     Document: 50     Page: 8    Filed: 09/14/2022
    8                              SAWSTOP HOLDING LLC    v. VIDAL
    IV
    With respect to the ’476 patent, Sawstop contends that
    any examiner rejection overturned on appeal, as was the
    examiner’s rejection of claim 11 in this case, qualifies as “a
    reversal of a determination of patentability,” regardless of
    any new grounds of rejection issued by the Board. Sawstop
    argues that the PTO and the District Court improperly in-
    terpreted the statutory expression “reverses an adverse de-
    termination of patentability” to add a new requirement
    that a decision in the review reversing an adverse determi-
    nation of patentability must not subject the claims at issue
    to a new rejection. According to Sawstop, the PTO reading
    finds no support in the statutory text nor serves the under-
    lying purpose of compensating the applicant for appellate
    delays that are not the applicant’s fault.
    The PTO counters by arguing that there was “no rever-
    sal of an adverse patentability determination” because
    claim 11 was unpatentable before and after the Board’s re-
    view in the appeal. According to the PTO, the Board’s set-
    ting aside of the rationale of the examiner’s obviousness
    rejection is irrelevant because it entered new reasoning to
    sustain that same rejection. It also asserts that because
    the Board maintained the unpatentability of claim 11, the
    ’476 patent could not have “issued under” the Board’s deci-
    sion.
    We do not find Sawstop’s argument persuasive. While
    there is no dispute that the Board cast aside the examiner’s
    basis for rejecting claim 11, the Board in the same review
    found claim 11 unpatentable, albeit for a different reason.
    The adverse determination of unpatentability remained
    before and after the appeal to the Board. The appeal thus
    resulted in no substantive change in the patentability of
    claim 11. Such a substantive change is required by the lan-
    guage of the statute itself: the reversal of a “determination
    of patentability” requires a determination that the claim in
    question is substantively allowable, not just free of a
    Case: 21-1537     Document: 50      Page: 9     Filed: 09/14/2022
    SAWSTOP HOLDING LLC    v. VIDAL                               9
    particular rejection. See Mayo Found. for Med. Educ. &
    Rsch. v. Iancu, 
    938 F.3d 1343
    , 1345 (Fed. Cir. 2019) (noting
    that Type C delay “provides PTA for each day the applica-
    tion is pending in . . . a successful appeal to the Patent Trial
    and Appeal Board . . . or a federal court” (emphasis added));
    Supernus, 913 F.3d at 1353 (“Type C adjustments are for
    delays that are . . . due to successful appeals.” (emphasis
    added) (citing 
    35 U.S.C. § 154
    (b)(1)(C)(iii))). We reject Saw-
    stop’s attempt to rewrite the statutory text to mandate
    PTA over reversal of a mere “rejection” or “basis for un-
    patentability.” Here, the appeal of the determination of pa-
    tentability of claim 11 was not “successful” as it was not
    “reversed.” The PTO faithfully applied the statutory text
    and did not improperly add a new requirement for eligibil-
    ity for (C) delay.
    The District Court also granted summary judgment on
    an independent basis: that claim 11 of the ’476 patent did
    not “issue under a decision in the review” because after the
    appeal, the claim was subject to a year of additional sub-
    stantive prosecution and amendments to address the
    Board’s new ground of rejection. As can be appreciated
    from the following side-by-side comparison, the claim as is-
    sued was not the same as the claim “under a decision in the
    review.”
    Case: 21-1537    Document: 50     Page: 10    Filed: 09/14/2022
    10                             SAWSTOP HOLDING LLC   v. VIDAL
    Sawstop challenges the District Court’s reasoning, ar-
    guing that the claim would not have issued but-for the suc-
    cessful appeal, and thus the “patent was issued under a
    decision in the review.” Again, we disagree. Under Saw-
    stop’s reading, the (C) delay provision could apply when an
    adverse determination of patentability is overcome on ap-
    peal, regardless of substantive amendments made after the
    appeal to secure allowance. This interpretation effectively
    reads out the phrase “in which the patent was issued under
    a decision in the review,” and thus cannot be sustained.
    See Hibbs v. Winn, 
    542 U.S. 88
    , 101 (2004) (“A statute
    should be construed so that effect is given to all its provi-
    sions, so that no part will be inoperative or superfluous,
    void or insignificant.”) (quoting 2A N. Singer, Statutes and
    Case: 21-1537    Document: 50      Page: 11     Filed: 09/14/2022
    SAWSTOP HOLDING LLC   v. VIDAL                              11
    Statutory Construction § 46.06, pp. 181–86 (rev. 6th ed.
    2000).
    The plain language of “issued under a decision in the
    review” means that at least one claim must “issue[] under”
    the mandate of the appellate decision. At a minimum, this
    means that at least one claim that “issued” must have been
    analyzed by the Board or District Court that issued the “de-
    cision in the review.” The statutory requirement is not met
    if the claim that ultimately issues differs substantively
    from the claim under review.
    Because claim 11 of the ’476 patent application was
    subject to an adverse determination of patentability both
    before and after the appeal, and because the claim issued
    only after significant substantive post-appeal prosecution
    and amendment, we affirm the District Court’s determina-
    tion that the ’476 patent did not “issue[] under a decision
    in the review reversing an adverse determination of pa-
    tentability” as that expression is used in 
    35 U.S.C. § 154
    (b)(1)(C)(iii).
    V
    The plain language of the (C) delay provision also com-
    pels affirmance as to claim 1 of the ’796 patent.
    Sawstop argues that the statute only requires the re-
    versal of “an adverse determination of patentability” and
    the PTO’s interpretation improperly replaces the statutory
    “an” with a requirement that “all” rejections of a particular
    claim be reversed. Sawstop’s argument again confuses spe-
    cific rejections with the determination of patentability. As
    noted supra, the singular reversal referenced in the statute
    is the determination of patentability of the claim under ap-
    pellate review, not a basis for a rejection or number of re-
    jections.
    We also reject Sawstop’s contention that the PTO’s in-
    terpretation of 
    35 U.S.C. § 154
    (b)(1)(C)(iii) fails to give ef-
    fect to the purpose of the statute. According to Sawstop,
    Case: 21-1537    Document: 50      Page: 12     Filed: 09/14/2022
    12                             SAWSTOP HOLDING LLC    v. VIDAL
    the purpose of the statute is to compensate applicants for
    certain reductions in patent term that are not the fault of
    the applicant. Such a broad reading overlooks the plain
    language of the statute, which is not nearly as sweeping as
    Sawstop contends. Sawstop provides no basis to support
    its contention that (C) delay was intended to categorically
    compensate applicants for all appellate delays that were
    not the applicant’s fault. As in Chudik, we do not find Saw-
    stop’s policy rationale a convincing reason to depart from
    the plain meaning of the statute. See Chudik, 987 F.3d at
    1034-35, 1040 (affirming a denial of (C) delay where the
    examiner repeatedly reopened prosecution to withdraw her
    own decision after the applicant filed a notice of appeal).
    Sawstop further contends that we should not read “re-
    versing an adverse determination of patentability” to re-
    quire that the claim be suitable for allowance following
    appeal because the separate patent term adjustment pro-
    vision for (A) delay, § 154(b)(1)(A)(iii), expressly references
    “allowable claims.” Sawstop is incorrect. The use of the
    phrase “allowable claims” in the (A) delay provision does
    not implicitly exclude considerations of allowability when
    reading the phrase “reversing an adverse determination of
    patentability” in the (C) delay provisions. Those provisions
    reflect different stages of prosecution during which delay
    may occur and the different reasons for such delay. The act
    giving rise to (A) delay is the PTO’s failure to act after an
    appellate decision “in a case in which allowable claims re-
    main in the application.” The phrase “allowable claims” in
    the (A) delay provision refers to the state of the claims
    when the triggering action—PTO inaction—takes place.
    This is a wholly different context than that of the (C) delay
    provision, “reversing an adverse determination of patenta-
    bility,” which accurately reflects that the appellate change
    of the patentability of the claims is itself the triggering
    event. The acts triggering (A) delay are thus unrelated to
    and independent of the acts giving rise to (C) delay, and
    Case: 21-1537    Document: 50     Page: 13    Filed: 09/14/2022
    SAWSTOP HOLDING LLC   v. VIDAL                            13
    may have no bearing on the determination of patentability
    under review in any particular appeal.
    Sawstop argues that the Board’s reversal of the exam-
    iner’s anticipation finding of claim 1 was a reversal of an
    adverse determination of patentability, and that the pres-
    ence of the provisional obviousness-type double patenting
    rejection was inapposite as to whether the Board reversed
    that adverse determination of patentability. The problem
    with Sawstop’s position is that the PTO’s “adverse deter-
    mination of patentability” of claim 1 of the ’796 patent was
    based on two grounds: double patenting and anticipation.
    Sawstop only appealed anticipation without addressing the
    provisional double patenting rejection. As a result, the Dis-
    trict Court for the District of Columbia understandably did
    not address the double patenting rejection. Sawstop’s suc-
    cess in reversing the anticipation rejection left the provi-
    sional double patenting rejection in place. Claim 1 of the
    ’796 patent was thus unpatentable both before the appeal
    (because of anticipation and double patenting) and after
    the appeal (because of double patenting). Like the ’496 pa-
    tent, the appellate decision did not reverse an adverse de-
    termination of patentability. See ’796 Decision, 
    2021 WL 2021122
    , at *6.
    Sawstop argues that the remaining rejection did not af-
    fect “patentability” because it was non-statutory (because
    it was an obviousness-type double patenting rejection) and
    provisional (because the obviousness-rendering reference
    was an application rather than a patent). Citing In re Mott,
    
    539 F.2d 1291
    , 1296 (C.C.P.A. 1976), Sawstop argues that
    these characteristics mean that the rejection did not have
    any force or effect until the obviousness-rendering refer-
    ence issued and was thus not a rejection that it could ap-
    peal or the District Court could affirm or reject. Sawstop
    is incorrect.
    First, Sawstop itself recognized that the rejection had
    legal effect as it appealed that rejection to the Board and
    Case: 21-1537    Document: 50     Page: 14   Filed: 09/14/2022
    14                             SAWSTOP HOLDING LLC   v. VIDAL
    did not claim it was illusory. Moreover, Sawstop never ex-
    plained why it could appeal the rejection to the Board un-
    der 
    35 U.S.C. § 134
    , but not to the D.C. District Court
    under 
    35 U.S.C. § 145
    . Second, on remand, claim 1 re-
    mained subject to the double patenting rejection, which be-
    came non-provisional following issuance of the application
    on which it was based. This occurred prior to issuance of
    the ’496 patent. To overcome that part of the adverse de-
    termination of patentability, Sawstop needed to either can-
    cel claim 1 and put claim 2 into independent form
    (Sawstop’s chosen action) or file a terminal disclaimer. Un-
    der either action, the patent was not allowable following
    the appeal in light of the pending rejection. For these rea-
    sons, we agree with the District Court that the appeal did
    not reverse an adverse determination of patentability as
    that expression is used in 35 U.S.C § 154(b)(1)(C)(iii).
    We also hold that the District Court was correct that
    the ’796 patent was ineligible for (C) delay for the inde-
    pendent reason that the ’796 patent did not issue under a
    decision in the review. The ’796 patent, as issued, did not
    include claim 1 as appealed. Rather, Sawstop cancelled
    claim 1 and replaced it with an independent form of claim
    2, which had been allowed in dependent form prior to the
    appeal. Sawstop fails to explain how the ’796 patent issued
    under a decision in the review. Sawstop argues in reply
    that the statute only requires that the “patent” issue under
    a decision in the review, not the “claim” that was the sub-
    ject of the appeal. However, that does not change the stat-
    utory text that the patent must issue under the decision in
    the review. Here, the only claim that was subject to the
    decision under review was claim 1, which was cancelled
    and thus not part of the issued patent. The ’796 patent
    therefore did not issue under a decision in the review.
    VI
    For the foregoing reasons, we affirm the judgments of
    the District Court that the PTO did not err in its
    Case: 21-1537    Document: 50      Page: 15    Filed: 09/14/2022
    SAWSTOP HOLDING LLC   v. VIDAL                             15
    interpretations of § 154(b)(1)(C)(iii) and did not violate the
    APA by refusing to award additional patent term adjust-
    ments for (C) delay for the ’796 patent and the ’476 patent.
    AFFIRMED